Elsasser T H, Richards M, Collier R, Hartnell G F
Growth Biology Laboratory, U.S. Department of Agriculture, Beltsville, MD 20705, USA.
Domest Anim Endocrinol. 1996 Jan;13(1):91-103. doi: 10.1016/0739-7240(95)00048-8.
The study determined 1) whether the pretreatment of calves with recombinant bovine somatotropin (bST, sometribove) would alter the change in packed cell volume (PCV), rectal temperature (RT), and the plasma concentrations of Ca2+, Fe2+, glucose (G), urea N (PUN), nonesterified free fatty acids (NEFA), albumin (ALB), and blood cell populations after endotoxin challenge (EC) and 2) whether the natural development of physiologic tolerance to repeated EC was affected by bST. Twelve steer beef calves were assigned to either control (-bST) or +bST treatment in equal numbers. Calves were injected intramuscularly with either HCO3(-)-buffered saline or bST (0.1 mg/kg) daily for 5 d. On Day 6, the first EC was administered (Escherichia coli, 055:B5, 0.2 microgram/kg, intravenous bolus in pyrogen-free saline). Saline or bST injections were continued from Day 7 up to the repeat of EC on Day 11. RT and PCV were measured hourly through 12 and 6 hr, respectively. Jugular blood was obtained at 0, +1, 2, 3, 4, 6, 8, 12, and 24 hr relative to each EC. bST had no effect on the increase in RT, the hyperglycemic phase of the G response, the biphasic change in Fe2+, or increases in NEFA and PUN. PCV increased after each EC only in -bST. The mean decrease in G during the hypoglycemic phase was less in +bST. Hypocalcemic responses were significantly less in +bST. ALB concentrations decreased after each challenge; the response was unaffected by bST. CD2+, CD4+, and CD8+ T-lymphocyte populations were unaffected by bST and EC. Overall, the magnitude of change in all plasma variables was less after the second EC compared with the first, either in terms of magnitude or duration. The data suggest that the treatment of calves with bST diminishes the magnitude of hypoglycemic, hypocalcemic, and PCV changes after EC and does not compromise fever response, changes in blood cell populations, or tolerance to repeated EC.
1)用重组牛生长激素(bST,sometribove)预处理犊牛是否会改变内毒素攻击(EC)后红细胞压积(PCV)、直肠温度(RT)以及血浆中Ca2+、Fe2+、葡萄糖(G)、尿素氮(PUN)、非酯化游离脂肪酸(NEFA)、白蛋白(ALB)的浓度和血细胞数量的变化;2)bST是否会影响对重复EC的生理耐受性的自然发展。12头肉用阉牛犊牛被平均分为对照组(-bST)和+bST处理组。犊牛每天肌肉注射HCO3(-)-缓冲盐水或bST(0.1 mg/kg),持续5天。在第6天,进行首次EC(大肠杆菌,055:B5,0.2微克/千克,在无热原盐水中静脉推注)。从第7天到第11天重复EC期间,继续注射盐水或bST。分别在12小时和6小时内每小时测量RT和PCV。在每次EC后的0、+1、2、3、4、6、8、12和24小时采集颈静脉血。bST对RT的升高、G反应的高血糖期、Fe2+的双相变化或NEFA和PUN的升高没有影响。仅在-bST组中,每次EC后PCV升高。在+bST组中,低血糖期G的平均下降幅度较小。在+bST组中,低钙血症反应明显较轻。每次攻击后ALB浓度下降;该反应不受bST影响。CD2+、CD4+和CD8+ T淋巴细胞群体不受bST和EC的影响。总体而言,与第一次相比,第二次EC后所有血浆变量的变化幅度在大小或持续时间方面均较小。数据表明,用bST处理犊牛可降低EC后低血糖、低钙血症和PCV变化的幅度,且不影响发热反应、血细胞数量变化或对重复EC的耐受性。